Results 111 to 120 of about 95,049 (250)

Short-Term Administration of HIV Protease Inhibitor Saquinavir Improves Skull Bone Healing with Enhanced Osteoclastogenesis. [PDF]

Plast Reconstr Surg, 2022
Liu H, Shen Y, Zhao B, Poon EH, Qi S, Ker DFE, Billiar TR, Cooper GM, Xu Y, Wang D.   +9 more
europepmc   +1 more source

Screening for bone health in older people with HIV: Uptake and outcomes from a large UK outpatient HIV service

HIV Medicine, EarlyView.
Abstract Objectives Bone health is negatively affected in people with HIV, and the risks of osteoporosis and fragility fractures are increased. The objective of this study was to describe the characteristics of those accessing bone health screening and identify factors associated with osteoporosis.
Rhys Nicholas, Kate Alford, Colin Fitzpatrick, Jaime Vera   +3 more
wiley   +1 more source

Semi-quantification and Potency Verification of the HIV Protease Inhibitor Based on the Matrix-Capsid Protein Immobilized Nickel (II)/NTA-Tol/Graphene Oxide/SPCE Electrochemical Biosensor. [PDF]

ACS Omega, 2023
Thongkum W, Klayprasert P, Semakul N, Jakmunee J, Kasinrerk W, Setshedi M, Sayed Y, Tayapiwatana C.   +7 more
europepmc   +1 more source

A multicentre evaluation of cardiovascular risk prediction tools in people living with HIV across England (ECARTH study)

HIV Medicine, EarlyView.
Abstract Introduction It remains unclear which cardiovascular disease (CVD) risk scores are optimized for people living with treated HIV with high rates of viral suppression. We evaluated the performance of commonly used CVD risk scores in a population of primarily well‐treated HIV patients in England.
Ming Jie Lee, Ashley Murray, Colette Smith, Zakee Abdi, Alastair Duncan, Ellen Dwyer, Mark Gompels, Merle Henderson, Margaret Johnson, Frances Lander, Gavin Manmathan, Jonathan Mok, Nnenna Ngwu, Coral Pratt, Iain Reeves, Razan Saman, Alice Sharp, Eleanor Taylor, Jhia Jiat Teh, Richard Stevens, Thomas R. Fanshawe, Jienchi Dorward, Ranjababu Kulasegaram, Anthony S. Wierzbicki   +23 more
wiley   +1 more source

HIV protease [PDF]

Science-Business eXchange, 2009
openaire   +3 more sources

Nutritional assessment and lipid profile in HIV-infected children and adolescents treated with highly active antiretroviral therapy Avaliação nutricional e do perfil lipídico em crianças e adolescentes infectadas pelo HIV tratadas com terapia antirretroviral de alta potência

Revista da Sociedade Brasileira de Medicina Tropical, 2011
INTRODUCTION: HIV-infected children and adolescents treated with highly active antiretroviral therapy (HAART) regimens that include a protease inhibitor (PI) can show significant improvements in clinical outcomes, nutritional status and quality of life ...
Marina Hjertquist Tremeschin, Daniela Saes Sartorelli, Maria Célia Cervi, Bento Vidal de Moura Negrini, Roberta Garcia Salomão, Jacqueline Pontes Monteiro   +5 more
doaj  

UltRaSoUnd‐guided evaLuAtion of metabolic health in a cohort of midlife women with HIV: The URSULA study

HIV Medicine, EarlyView.
Abstract Objectives We aimed to determine the prevalence of metabolic disorders, liver steatosis and metabolic dysfunction‐associated steatotic liver disease (MASLD) in a cohort of middle‐aged women with HIV (WoWH) and to explore associations between liver steatosis, visceral fat depots and carotid atherosclerosis.
Mariacristina Poliseno, Davide Capruzzi, Antonio Cianciaruso, Nicola Colavito, Felicia Dalitto, Vincenzo Giliberti, Vittoria Lobalsamo, Giuliana Metrangolo, Marica Noviello, Alessandra Vigna, Maurizio Zarcone, Francesco Di Gennaro, Vincenzo Ostilio Palmieri, Annalisa Saracino   +13 more
wiley   +1 more source

Revertant mutation V48G alters conformational dynamics of highly drug resistant HIV protease PRS17. [PDF]

J Mol Graph Model, 2021
Burnaman SH, Kneller DW, Wang YF, Kovalevsky A, Weber IT.   +4 more
europepmc   +1 more source

Characteristics and management of low‐level viraemia in people living with HIV in a resource‐limited setting: A multicentre retrospective study in Greece

HIV Medicine, EarlyView.
Abstract Objectives Low‐level viraemia (LLV) persists in some people living with HIV despite antiretroviral therapy, raising concerns about virologic failure. We assessed the characteristics, management and outcomes of LLV in Greece, where next‐generation sequencing, therapeutic drug monitoring and electronic adherence monitoring are unavailable ...
Lydia Leonidou, Giota Lourida, Konstantinos Protopapas, Charalampos D. Moschopoulos, Dimitrios Zoulas, Charisis Totsikas, Dimitrios Basoulis, Elpida Mastrogianni, Apostolos Beloukas, Maria Lagadinou, Markos Marangos, Vasileios Papastamopoulos, Antonios Papadopoulos, Mina Psichogiou   +13 more
wiley   +1 more source

Suspected bradycardia due to interactions between HIV protease inhibitors and lidocaine: a case report. [PDF]

J Dent Anesth Pain Med, 2021
Hamaya E, Kamekura N, Fujisawa T.
europepmc   +1 more source